Author:
Kozhakhmetov Samat,Kushugulova Almagul,Kakimova Akbota,Nurgozhin Talgat,Zhumadilov Zhaksybay
Publisher
JSC National Scientific Medical Research Center
Reference41 articles.
1. Meshkov A.N. Gipolipidemicheskaya effektivnost’ rosuvastatina v sravnenii s drugimi statinami (Lipid-lowering efficacy of rosuvastatin compared with other statins), Ratsyonal’naya farmakoterapiya v kardiologii, 2012, Vol. 8, No 5, pp. 691-693.
2. Wolffenbuttel B.H., Franken A.A., Vincent H.H. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study, J Intern Med.,2005, Vol. 257, No.6, pp. 531-539.
3. Betteridge D.J., Gibson J.M., Sager P.T. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study), Am J Cardiol., 2007,Vol. 100, No. 8, pp. 1245-1248.
4. Berne C., Siewert-Delle A. Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study, Cardiovasc Diabetol., 2005, Vol. 4, p.7.
5. Wijndaele K., Duvigneaud N., Matton L.et al. Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults, Eur J Clin Nutr., 2009. Vol. 63, No 3, pp. 421-429.